IPO Winners & Losers

25 Episodes
Subscribe

By: Renaissance Capital

IPO Winners & Losers from Renaissance Capital is your weekly briefing on the IPO market.Each episode breaks down the biggest IPO news, new listings, and market trends shaping deal flow: what’s working, what’s not, and what it means for investors.Built as a companion to our weekly newsletter, The IPO Market's Winners and Losers Last Week, this podcast turns market analysis into a fast, conversational format.Stay ahead of the next generation of public companies. Get the newsletter in your inbox every week: https://ipos.renaissancecapital.com/l/1104911/2025-11-04/7p1rtn

✂️ Clip this podcast
IPO Winners & Losers: Anthropic vs. the AI Selloff
#25
Today at 9:00 AM

Welcome back to Renaissance Capital’s IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• Anthropic still hasn’t filed publicly, putting its pre-Thanksgiving IPO timeline in doubt
• Lycia Therapeutics jumps nearly 67% after an upsized, top-of-range biotech IPO  
• AI infrastructure names remain under pressure as investors question spending, debt, and valuations
• OPay moves ahead with a roughly $320 million IPO as profitable growth continues to find buyers
• Software leads again while AI infrastructure stocks remain the weak...


IPO Winners & Losers: AI Gets Repriced, Biotech Breaks Out, and Anthropic Approaches
#24
10/18/2026

Welcome back to Renaissance Capital’s IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• Anthropic’s potential mega-IPO gets repriced as its rumored valuation falls to around $1.5 trillion
• Iambic Therapeutics surges 49% and City Therapeutics rises 24% as healthcare defies the broader selloff
• AI infrastructure stocks get hit hard as inflation and rate concerns return
• Bending Spoons jumps again after an investment from Berkshire Hathaway
• The Q4 IPO calendar narrows as issuers wait on Anthropic, mar...


IPO Winners & Losers: Software Surges, Biotech Stumbles, and Unicorns Wait
#23
10/11/2026

Welcome back to Renaissance Capital’s IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• Software stocks surge as the sector hits a year-to-date high  
• Biotech’s hot IPO streak gets a reality check after two weak debuts  
• Iambic and City Therapeutics prepare to test whether stronger biotech names can still command demand  
• DayOne Data Centers and African fintech OPay join a growing IPO pipeline  
• Wall Street waits on Anthropic as the broader IPO market treads...


IPO Winners & Losers: Oura IPO Stalls, Software Rallies, and Anthropic Looms
#22
10/04/2026

Welcome back to Renaissance Capital’s IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• Oura postpones its $2.1 billion IPO as investors push back on valuation
• Accelevation gets its deal done, but only after pricing below the range
• Four IPOs are pulled in two weeks as buyers demand bigger discounts
• Software stocks rally while AI hardware names lose momentum
• Anthropic’s expected November IPO begins to shape the entire Q4 calendar

We also discus...


IPO Winners & Losers: Oura, Bonds, and More AI Infrastructure
#21
09/27/2026

Welcome back to Renaissance Capital’s IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• Oura prepares to test the market with a nearly $15 billion valuation
• ADARx Pharmaceuticals rises after a $446 million biotech IPO backed by AbbVie
• Bamboo Insurance postpones its offering as buyers push back on valuation and deal structure
• Accelevation tests whether demand for AI infrastructure IPOs is still alive
• The IPO Index keeps outperforming even as the bond market sells off

We...


IPO Winners & Losers: Rates Rise, Nscale Files, and SpaceX Joins the Index
#20
09/20/2026

Welcome back to Renaissance Capital’s IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• The Fed raises rates for the first time in three years, forcing IPO issuers to rethink timing and valuation
• Holtec Nuclear postpones its $825 million IPO as the AI power trade cools
• American Savings Bank stands out as the only new listing to trade higher
• The fall IPO pipeline stays deep, with AI infrastructure, consumer, software, and financial names still waiting in...


IPO Winners & Losers: Fall IPOs Trickle In, Nuclear Lines Up, and Anthropic Waits
#19
09/13/2026

Welcome back to Renaissance Capital’s IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• The fall IPO market gets moving, but launches come in lighter than expected
• Holtec Nuclear prepares to test investor appetite for a battered nuclear theme
• Anthropic delays its filing timeline again, pushing a potential listing deeper into the fall
• Hot CPI, $100 oil, and near-5% Treasury yields pressure growth stocks and IPO sentiment
• Venture Global rallies while ServiceTitan plunges after a weak...


IPO Winners & Losers: Oura, Software, and the Fall IPO Pickup
#18
09/06/2026

Welcome back to Renaissance Capital’s IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• The fall IPO calendar comes alive with up to eight potential launches after Labor Day
• Anthropic’s public filing could land at any moment and reshape the entire quarter
• SB Energy files for a potential $5 billion-plus IPO backed by a massive data center backlog
• Oura enters the pipeline as consumer IPO activity continues to broaden
• Entrata revives its IPO plans as s...


IPO Winners & Losers: Anthropic Looms, AI Power Rebounds, and the Fall Pipeline Waits
#17
08/30/2026

Welcome back to Renaissance Capital’s IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• Anthropic reportedly prepares to file after Labor Day for a fall IPO
• Aggreko joins the pipeline with a $1.5 billion AI-power offering
• The fall IPO pipeline builds more slowly than expected as issuers wait on the tape
• Nvidia’s latest earnings reaction offers a potential positive signal for AI infrastructure
• Tech names lead while aerospace stocks retreat on earnings and valuation...


IPO Winners & Losers: Anthropic’s Mega IPO, OpenAI Steps Back, and AI Infra Cracks
#16
08/23/2026

Welcome back to Renaissance Capital’s IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• Anthropic moves closer to a potential October IPO that could top SpaceX’s record
• OpenAI appears to step back from the near-term IPO race
• Lyntris closes out the summer calendar with a disappointing debut
• Klarna plunges 31% after lowering guidance despite a strong quarter
• Tempus AI jumps 40% as investors reward a real catalyst amid broader AI weakness

We also discus...


IPO Winners & Losers: Anthropic’s $2T Bid, CoreWeave’s Comeback, and the Fall IPO Setup
#15
08/16/2026

Welcome back to Renaissance Capital's IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• Anthropic investors reportedly eye a $2 trillion valuation for a potential October IPO
• SpaceX’s record as the largest IPO ever could be broken just months after it was set
• CoreWeave rebounds sharply as AI infrastructure stocks regain momentum
• Biotech quietly extends one of the strongest IPO streaks of 2026
• Lyntris prepares to close out the summer IPO calendar with a defense tech...


IPO Winners & Losers: New Stocks Surge, Biotech Booms, and AI Rallies
#14
08/08/2026

Welcome back to Renaissance Capital's IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• The IPO Index surges 8.6%, reversing three straight down weeks and climbing back above 20% for the year
• Biotech goes four-for-four, led by Braveheart Bio’s 65% first-week pop
• SpaceX rallies 23% through its first earnings report and closely watched lock-up release
• The summer IPO window enters its final week as issuers decide whether to launch now or wait for September
• AI diagnostics split sharpl...


IPO Winners & Losers: Biotech Soars, Jersey Mike's Misses, and SpaceX Faces the Lockup
#13
08/02/2026

Welcome back to Renaissance Capital's IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• Jersey Mike's raises more than $1 billion but struggles to deliver a convincing debut
• Reformation shows consumer IPOs can work when they price (arguably) conservatively
• Apnimed surges 56% as biotech remains one of the market's strongest themes
• Ionic Digital completes the largest direct listing since 2021
• SpaceX prepares for its first earnings report and a massive lock-up release

We also discuss wh...


IPO Winners & Losers: Jersey Mike's, Bubble Baths, and Biotech Wins
#12
07/25/2026

Welcome back to Renaissance Capital's IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market. 

Get the newsletter in your inbox every week.

This week: 
• Scribe Therapeutics pops 44%, with strategic investments from Eli Lilly and Sanofi 
• Jersey Mike's preps the largest consumer IPO in 2+ years at an $8.9 billion valuation 
• Reformation prepares to be the market's first DTC name in years 
• Ionic Digital's direct listing tests the bitcoin-miner-to-data-center pivot 
• The IPO Index slips alongside a broader growth selloff on AI concerns and the Iran war

We also dis...


IPO Winners & Losers: SpaceX Breaks, AI Cracks, and Software Strikes Back
#11
07/18/2026

Welcome back to Renaissance Capital's IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• SpaceX falls below its IPO price for the first time
• Csquare and Standard Nuclear stumble as the AI infrastructure trade loses momentum
• The IPO Index drops sharply alongside the broader AI selloff
• Software names like SailPoint and Figma rally as investors rotate away from AI
• Jersey Mike's and Cumberland Farms prepare to test demand for consumer IPOs

We also di...


IPO Winners & Losers: SK hynix, Mega IPOs, and Hidden Volatility
#10
07/12/2026

Welcome back to Renaissance Capital's IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• SK hynix raises $26.5 billion in one of the largest new listings ever
• US IPO proceeds approach 2021’s all-time record after a massive 30-day run
• AI infrastructure continues to define the 2026 IPO market
• Csquare and Standard Nuclear test demand for data centers and nuclear fuel
• IPO volatility stays high beneath a calm-looking VIX

We also discuss why SK hynix’s US l...


IPO Winners & Losers: SK hynix, AI Infra Risk, and Sandwiches
#9
07/05/2026

Welcome back to Renaissance Capital's IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• The IPO Index caps off its best quarter in years, outpacing the S&P 500 by a wide margin
• Bending Spoons pops after pricing above the range, showing software can still find demand
• Lime finally gets its IPO window after years of waiting
• SK hynix prepares for a massive US cross-listing tied to the AI memory boom
• Jersey Mike's and Cumberland...


IPO Winners & Losers: Q2 Breakout, Cerebras Cracks, and Theme Wins
#8
06/28/2026

Welcome back to Renaissance Capital’s IPO Winners and Losers — the weekly podcast breaking down the biggest stories shaping the IPO market, new stocks, and Wall Street sentiment.

Get the newsletter in your inbox every week.

This week:
• The IPO market caps off a blowout Q2, with the IPO Index absolutely ripping
• AI-linked new stocks pull back as Cerebras breaks below its IPO price for the first time
• Doncasters soars by tapping into aerospace and AI power demand
• DSC Holdings delivers one of the worst IPO debuts in decades
• SK hynix files fo...


IPO Winners & Losers: Great Tape, OpenAI Leaks, and the Filing Gap
#7
06/21/2026

Welcome back to Renaissance Capital’s IPO Winners and Losers — the weekly podcast breaking down the biggest stories shaping the IPO market, new stocks, and Wall Street sentiment.

Get the newsletter in your inbox every week.

This week:
• The IPO Index keeps surging, up more than triple the S&P 500 year-to-date
• SpaceX holds up in the aftermarket and reaches a market cap near Amazon
• The IPO rally looks strong, but new filings remain the missing piece
• Kardigan leads a mixed holiday-week IPO lineup as biotech stays hot
• OpenAI’s leaked financials show...


IPO Winners & Losers: SpaceX's Goldilocks Debut, OpenAI's Move, and IPO Discipline
#6
06/14/2026

Welcome back to Renaissance Capital’s IPO Winners and Losers — the weekly podcast breaking down the biggest stories shaping the IPO market, new stocks, and Wall Street sentiment.

Get the newsletter in your inbox every week.

This week:
• SpaceX IPO makes history and delivers a "Goldilocks" debut
• The stock rises 19% on day one, validating demand without flashing obvious froth
• OpenAI officially joins the IPO backlog after SpaceX validates the playbook
• Parabilis completes a record biotech IPO while other deals fall flat in SpaceX’s shadow
• The IPO Index keeps outperforming, but software rem...


IPO Winners & Losers: SpaceX Terms, Selective Investors, and the AI IPO Race
#5
06/07/2026

Welcome back to Renaissance Capital's IPO Winners and Losers — the weekly podcast breaking down the biggest stories shaping the IPO market, new stocks, and Wall Street sentiment.

Get the newsletter in your inbox every week.

This week:
• SpaceX sets terms for what could be the largest IPO in history
• Retail investors may get a record allocation in the SpaceX offering
• INNIO pops while Quantinuum gives quantum IPOs a reality check
• Liftoff Mobile opens the door for the first major software IPO of the year
• Anthropic confidentially files as the mega-IPO race acceler...


IPO Winners & Losers: Two Storms, the Big Three, and Software's Return
#4
05/31/2026

Welcome back to Renaissance Capital’s IPO Winners and Losers — the weekly podcast breaking down the biggest stories shaping the IPO market, new stocks, and Wall Street sentiment.

Get the newsletter in your inbox every week.

This week:
• The IPO market rallies as recent new stocks continue to outperform
• Seven IPOs line up for one of the busiest weeks since 2021
• SpaceX prepares to launch its roadshow into a red-hot market
• Liftoff Mobile tests whether the software IPO window is finally reopening
• OpenAI, Anthropic, and SpaceX reshape the 2026 mega-IPO calendar

We also di...


IPO Winners & Losers: Summer of SpaceX
#3
05/24/2026

Welcome back to Renaissance Capital’s IPO Winners and Losers — the weekly podcast breaking down the biggest stories shaping the IPO market, new stocks, and Wall Street sentiment.

Get the newsletter in your inbox every week.

This week:
• SpaceX files for what could be the largest IPO in history
• The post-Memorial Day IPO window gets crowded as issuers race to price before SpaceX dominates attention
• Starlink, AI infrastructure, cash burn, governance, and Mars incentives define the SpaceX S-1
• OpenAI reportedly files confidentially, setting up a potential fall mega-IPO
• The IPO Index surges a...


IPO Winners & Losers: Cerebras, SpaceX, and the AI Takeover
#2
05/17/2026

Welcome back to Renaissance Capital’s IPO Winners and Losers — the weekly podcast breaking down the biggest stories shaping the IPO market, new stocks, and Wall Street sentiment.

Get the newsletter in your inbox every week.

This week:
• 2026 IPO proceeds jump from $18 billion to $28 billion in one week
• Cerebras prices the largest AI IPO ever — then faces an immediate test in the aftermarket
• The IPO market rewards “lottery ticket” growth stories while defensive deals struggle
• SpaceX is poised to be the first mega IPO, with a potential filing on deck for next week
• An...


IPO Winners & Losers: Defense Tech Wins, Big AI Bets, and the IPO Window
#1
05/10/2026

Welcome to Renaissance Capital’s IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market.

Get the newsletter in your inbox every week.

This week:
• The IPO market looks strong on the surface — but is it running on FOMO?
• Defense and AI-linked IPOs surge while consumer names struggle
• Cerebras prepares for the largest AI IPO ever
• Three billion-dollar AI infrastructure deals test the market next week
• Lime files for an IPO years after its SPAC-era ambitions faded

We also discuss why the current IPO wi...